Evaluation of Tibial Nerve Selective Neurotomy Compared to Botulinum Toxin Injections for Spastic Foot Treatment in Post-stroke Patients According to a Goal-centered Approach (FOOTNEUROTOX)
Post Stroke Seizure, Spastic Foot
About this trial
This is an interventional other trial for Post Stroke Seizure focused on measuring Tibial nerve selective neurotomy, botulinum toxin, spastic foot, post-stroke patient
Eligibility Criteria
Inclusion Criteria: Adult patients (older than 18 years) Man and woman Hemiparesis secondary to stroke (delay from stroke > 1 year) Foot with equinovarus with or without toe claw due to spasticity of at least the triceps surae and /or one of the following muscles: tibialis posterior, flexor digitorum and hallucis longus muscles. Spasticity confirmed with no isolated tendon shortening diagnosed using tibialis nerve block under local anesthesia with at least a 5 degrees gain in passive or active ankle dorsal flexion. Covered by National French insurance Able to understand French and the purpose of the study Informed consent signed by the patient or consent obtained from a relative or trusted person of the patient Exclusion Criteria: Known sensitivity to BoNT or botulinum toxin A excipients Contraindication to surgery under general anesthesia History of myasthenia Pregnant woman (confirmed by urinary test) or breastfeeding Patient under legal protection Patients unable to follow the requirement of the study according to the investigator or supported by a family member
Sites / Locations
- Hôpital Pierre Wertheimer
- AP-HP
- CHU de Nantes
- Hôpital Henry Gabrielle
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Tibial nerve selective neurotomy
Botulinum toxin injection